EHMT2 and pancreatitis: Thus, EHMT2 inactivation appears play a role in regulating pancreatitis-enhanced KrasG12D effects, not only through cell growth regulatory pathways, but also in part via immunomodulatory effects, thereby affecting the tumor microenvironment.